Open AccesscMET inhibitor crizotinib impairs angiogenesis and reduces tumor burden in the C3(1)-Tag model of basal-like breast cancer
Author(s) -
Alyssa J. Cozzo,
Sneha Sundaram,
Ottavia Zattra,
Yuanyuan Qin,
Alex J. Freemerman,
Luma Essaid,
David B. Darr,
Stephanie A. Montgomery,
Kirk K. McNaughton,
J. Ashley Ezzell,
Joseph A. Galanko,
Melissa A. Troester,
Liza Makowski
Publication year - 2016
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/665e-3747
Subject(s) - crizotinib , angiogenesis , breast cancer , angiogenesis inhibitor , basal (medicine) , cancer , cancer research , medicine , oncology , lung cancer , insulin , malignant pleural effusion
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom